 Among 28 centers across the U.S., 89% reported that at least one drug used to treat cancer, its symptoms, or treatment side effects was in short supply. That's according to a survey by the National Comprehensive Cancer Network. The problem is reportedly fueled by a combination of supply chain issues and overseas companies cutting back on unprofitable drug manufacturing. I'm Tammy Trujillo.